#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	5094	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2579	585.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1971	1971	T	760	T,C,G	669,3,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	5094	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2579	585.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1705	1705	C	768	C,A,G	630,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8224	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3832	641.1	0	.	n	.	0	T695C	SNP	695	695	T	1145	1145	C	566	C,A	469,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8224	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3832	641.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1787	1787	A	727	A,G,C	622,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8224	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3832	641.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	2088	2088	G	776	G,A,T	667,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8224	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3832	641.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2421	2421	C	790	C	669	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8224	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3832	641.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2495	2495	A	823	A,C	705,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8224	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3832	641.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3047	3047	C	724	C,A	613,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8224	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3832	641.1	0	HET	.	.	.	C2525T,G,A	.	2525	2525	C	2975	2975	C	767	C,T,G,A	477,174,2,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	798	folP	855	855	100.0	folP.l6.c17.ctg.1	1884	126.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1164	1166	AGC	165;165;165	A;G;C	136;141;135	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1532	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3884	118.1	1	SNP	p	S91F	1	.	.	271	273	TTC	754	756	TTC	136;136;136	T;T;C,A	115;117;117,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1532	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3884	118.1	1	SNP	p	D95G	1	.	.	283	285	GGC	766	768	GGC	132;132;133	G;G;C	113;114;118	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1532	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3884	118.1	1	SNP	p	G95N	0	.	.	283	285	GGC	766	768	GGC	132;132;133	G;G;C	113;114;118	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	790	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1718	137.3	1	SNP	p	G45D	0	.	.	133	135	GGC	585	587	GGC	225;225;225	G;G,T;C,T	200;198,2;199,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	484	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1283	112.4	0	.	n	.	0	A197.	DEL	197	197	A	719	719	A	194	A	175	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1760	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3283	160.6	1	SNP	p	D86N	0	.	.	256	258	GAC	739	741	GAC	192;192;194	G;A,C;C	164;155,1;165	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1760	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3283	160.6	1	SNP	p	R87I	0	.	.	259	261	CGT	742	744	CGT	194;193;193	C,A;G;T	167,1;166;159	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1760	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3283	160.6	1	SNP	p	R87W	0	.	.	259	261	CGT	742	744	CGT	194;193;193	C,A;G;T	167,1;166;159	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1760	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3283	160.6	1	SNP	p	S87R	1	.	.	259	261	CGT	742	744	CGT	194;193;193	C,A;G;T	167,1;166;159	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1760	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3283	160.6	1	SNP	p	S88P	0	.	.	262	264	TCC	745	747	TCC	193;194;194	T,C;C;C,A	160,1;166;162,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1340	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3145	127.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1782	1784	GGC	147;146;146	G;G;C,T	127;126;128,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.41.001	penA.41.001	1	1	27	1316	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2825	139.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1491	1493	GCA	222;225;224	G;C;A	177;182;182	penA.41.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1316	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2825	139.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1494	1496	ATC	222;222;222	A;T;C	183;181;183	penA.41.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1316	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2825	139.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1506	1508	GTG	217;217;219	G;T,G;G	180;177,1;177	penA.41.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1316	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2825	139.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1506	1508	GTG	217;217;219	G;T,G;G	180;177,1;177	penA.41.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1316	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2825	139.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2010	2012	ACC	157;157;156	A,T;C;C	133,1;141;143	penA.41.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1316	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2825	139.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2064	2066	GCG	155;156;155	G;C;G,T	129;124;114,1	penA.41.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1316	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2825	139.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2064	2066	GCG	155;156;155	G;C;G,T	129;124;114,1	penA.41.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1316	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2825	139.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2187	2189	AGC	141;143;143	A,C;G;C	113,3;115;118	penA.41.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1316	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2825	139.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2196	2198	GGC	145;145;146	G;G;C,T	122;121;122,1	penA.41.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1316	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2825	139.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2214	2216	CCG	151;151;151	C,T,A;C;G	115,1,1;123;116	penA.41.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1704	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3622	141.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1918	1920	CCG	138;138;138	C;C;G	104;116;107	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	916	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2345	117.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	893	893	C	145	C	123	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1096	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2034	161.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	595	597	GAA	222;222;221	G;A,C;A,C	190;189,1;192,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1096	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2034	161.2	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	844	846	AAC	214;215;216	A,G;A;C	178,1;188;186	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1096	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2034	161.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	883	885	GAT	217;216;216	G;A;T,C	184;181;178,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1096	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2034	161.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1006	1008	TCA	207;208;210	T;C,G;A	175;178,1;183	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1096	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2034	161.2	0	.	p	.	0	A218I	NONSYN	652	654	GCC	1135	1137	ATC	222;223;225	A,C;T,A,C;C	191,1;177,1,1;187	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1096	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2034	161.2	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1255	1257	CAT	235;235;235	C,T;A,G;T	193,1;196,1;197	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1096	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2034	161.2	0	.	p	.	0	S295G	NONSYN	883	885	AGT	1366	1368	GGT	247;245;244	G;G;T	207;205;207	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1096	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2034	161.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1465	1467	GCA	237;238;235	G;C;A	196;192;190	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1096	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	2034	161.2	1	SNP	p	G120K	1	.	.	358	360	AAG	841	843	AAG	215;215;214	A,C;A;G	181,1;177;185	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3304	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5411	183.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	504	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1614	93.8	1	SNP	p	V57M	1	.	.	169	171	ATG	821	823	ATG	186;186;183	A;T;G	157;160;152	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
